Thrombophilia due to thrombin defect
MONDO:0008559The formation of a blood clot (thrombus) in the lumen of a vein.
Also known as: Venous thromboembolism, prothrombin thrombophilia, prothrombin-related thrombophilia, thrombophilia 1 due to thrombin defect, thrombophilia due to thrombin defect, venous thromboembolism, susceptibility to, venous thrombosis, protection against, THPH1
22 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Which vein is safer for chemotherapy ports? a trial aims to settle the debate
Disease control CompletedThis trial compares two common methods for placing a totally implantable vascular access device (TIVAD), a port used for chemotherapy and other treatments in cancer patients. Researchers are randomly assigning patients to have the port inserted via either the internal jugular vei…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Battlefield plasma goes civil: can a powder save trauma victims?
Disease control CompletedThis study tested a freeze-dried plasma product that can be mixed with water in 6 minutes, avoiding the long thaw time of standard plasma. It included 42 trauma patients with severe bleeding who needed blood transfusions. The goal was to see if faster plasma delivery could improv…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New Clot-Busting catheter shows promise in leg vein blockages
Disease control CompletedThis study looked at how well the JETi device works in real-world settings to remove blood clots from deep leg veins (venous thrombosis). The device uses suction and tiny water jets to break up and remove clots. In 121 patients, the device successfully cleared at least 75% of the…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood thinners after vein laser: which works best to stop dangerous clots?
Prevention CompletedThis trial tests whether a short 5-day course of the blood thinners rivaroxaban (Xarelto) or apixaban (Eliquis) can prevent blood clots that sometimes form after laser treatment for varicose veins. Adults with symptomatic vein reflux undergoing laser ablation of the great sapheno…
Phase: PHASE4 • Sponsor: Heart, Artery, and Vein Center of Fresno • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Which blood thinner works best after joint surgery? huge study reveals answers
Prevention CompletedThis study compared three common blood thinners—aspirin, warfarin, and rivaroxaban—to prevent dangerous blood clots after hip or knee replacement surgery. Nearly 19,000 adults took part. The goal was to find which option best balances preventing clots with avoiding bleeding side …
Phase: PHASE4 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Scientists hunt for clot clues in sickle cell blood
Knowledge-focused CompletedThis study examined blood samples from 119 adults with sickle cell disease, sickle cell trait, or no condition to understand why some develop dangerous blood clots. Participants gave blood and had health check-ins over two years. The goal was to find biomarkers that could lead to…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Hidden danger: abuse may double blood clot risk for women on the pill
Knowledge-focused CompletedThis completed study looked at whether intimate partner violence (IPV) increases the risk of blood clots in women taking combined oral contraceptives. Researchers compared 997 women who had a first blood clot with similar women who did not, using a questionnaire to screen for IPV…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Blood DNA levels may signal pregnancy problems
Knowledge-focused CompletedThis study measured the amount of free-floating DNA and nucleosomes in the blood of 137 women to see if these levels differ between those with pregnancy complications (like preeclampsia or blood clots) and healthy women (both pregnant and non-pregnant). The goal was to better und…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC